PROTACs in Radiosensitization
Kancure is developing PROTACs that can cross blood brain barrier (BBB) to treat CNS diseases such as primary brain tumor, brain metastasis, and degenerative brain diseases.
E3 Ligases in Human Diseases
Our leading PROTACs can penetrate BBB and can target degradation of key pro-survival proteins in glioma. Also, we are developing developing platforms by designing and synthesizing new E3 ligases ligands/inhibitors.